RAUVI BLACKWELL: Open Payments
NPI 1609319052 · LEWISVILLE, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$363 in 19 payments from 10 companies in 2025. Trend: 2023 $184 · 2024 $48 · 2025 $363
Food & beverage: $363
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 4 | $73 |
| Neurocrine BioSciences, Inc. | 4 | $71 |
| Lundbeck LLC | 2 | $48 |
| Alkermes, Inc. | 2 | $42 |
| Vanda Pharmaceuticals Inc. | 2 | $40 |
| Janssen Pharmaceuticals, Inc | 1 | $20 |
| Teva Pharmaceuticals USA, Inc. | 1 | $18 |
| Noven Therapeutics, LLC | 1 | $18 |
| E.R. Squibb & Sons, L.L.C. | 1 | $17 |
| Collegium Pharmaceutical, Inc. | 1 | $17 |
Products named: REXULTI, INGREZZA, ARISTADA, FANAPT, ABILIFY ASIMTUFII, INVEGA SUSTENNA, UZEDY, Secuado.
Industry payments across TX — which companies pay providers there.
